期刊文献+

2型糖尿病合并大血管病变患者血流变检测结果分析 被引量:7

Analysis of Hemorheological Parameters in Type 2 Diabetes with Macro-vascular Complications
下载PDF
导出
摘要 目的观察2型糖尿病及其合并大血管病变患者血流变学指标的变化。方法应用YDA2Ⅳ血液粘度仪测定全血粘度及血浆粘度(mPa.s),应用全自动血细胞分析仪测定红细胞压积(L/L)。结果正常对照组全血粘度、血浆粘度及红细胞压积显著低于2型糖尿病无大血管病变组(P<0.05)和2型糖尿病合并大血管病变组(P<0.01);2型糖尿病合并大血管病变组全血粘度、血浆粘度及红细胞压积显著高于2型糖尿病无大血管病变组(P<0.05)。结论长期、反复跟踪检测患者血流变学指标的变化,有助于提前预测2型糖尿病患者合并大血管病变的发生。 Objective To observe the changes of hemorheologieal parameters in type 2 diabetes with macro- vascular complications. Methods The hemorrheology indices including whole blood viscosity, plasma viscosity and hematocfit in blood. Results The whole blood viscosity, plasma viscosity and hematocfit in blood of normal human were significantly lower than those of in type 2 diabetes patients without macro - vascular complications ( P 〈 0. 05 ), and lower than those of in type 2 diabetes patients with macro - vascular complications ( P 〈 0.01 ). The whole blood viscosity, plasma viscosity and hematocrit in blood of type 2 diabetes patients with macro - vascular complications were signitlcantly higher than those of in type 2 diabetes patients without macro - vascular complications ( P 〈 0.05 ). Collclusion Detective the changes of hemorheological parmeters in type 2 diabetes in long - term could be help the anticipation the occur of macrovascular complications.
作者 陈宝琴 王虹
出处 《中国实验诊断学》 2007年第6期759-760,共2页 Chinese Journal of Laboratory Diagnosis
关键词 糖尿病 大血管病变 血流变 Type 2 Diabetes Macro - vascular Complications Haemorheology
  • 相关文献

参考文献5

二级参考文献16

  • 1洼田富.糖尿病性肾病诊断与治疗[J].1993,81(9).
  • 2Morishita R,Nakmura S,Hayashi S,et al.Contribution of a vascular modulator,hepatocyte growth factor (HGF),to the pathogenesis of cardiovascular disease[J].J Atheroscler Thromb,1998,5 (4):128-134.
  • 3Morishita R,Nakamura S,Nakamura Y,et al.Potential role of endothelium-specific growth factor,hepatocyte growth factor,an endothelial damage in diabetes mellitus[J].Diabetes,1997,46 (7):138-148.
  • 4Nakamura S,Morishita R,Moriguchi A,et al.Hepatocyte growth factor as a potential index of complication in diabetes mellitus[J].J Hypertens,1998,16(9):2 019-2 026.
  • 5Haug C,Schmid-Kotsas A,Zorn U,et al.Hepatocyte growth factor is unregulated by low-density lipoproteins and inhibits endothelin-1 release[J].Am J Physiol,2000,279(12):2 865-2 871.
  • 6Nishimura M,Ushiyma M,Ohtsuka K,et al.Serum hepatocyte growth factor as a possible indicator of vascular lesions[J].J Clin Endocrinol Metab,1999,84(11):2 475-2 480.
  • 7Nakamura M,Moriguchi A,Morishita R,et al.A novel vascular modulator,hepatocyte growth factor (HGF),as a potential index of the severity of hypertension[J].Biochem Biophys Res Commun,1998,242 (5):238-249.
  • 8Nakamura Y,Morishita R,Nakamura S,et al.A vascular modulator,hepatocyte growth factor is associated with systolic pressure[J].Hypertension,1996,28 (6):409 -413.
  • 9Morishita R,Moriguchi A,Higaki J,et al.Hepatocyte growth factor (HGF) as a potential index of severity of hypertension[J].Hypertens Res,1999,22 (5):161-167.
  • 10Kawamoto R,Oka Y,Yoshida O,et al.Significance of serum circulating hepatocyte growth factor in the development of carotid atherosclerosis[J].J Atheroscler Thromb,2003,10 (3):154 -159.

共引文献18

同被引文献67

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部